Studies
PD-1 Blockade in Non-Small Cell Lung Cancer
PD-1 Blockade in Non-Small Cell Lung Cancer
Request Access
Overview
Selected Publications (2)
Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer
N. Rizvi, M. Hellmann, A. Snyder, et al.. (2015). Science. Cited 6,463 times.
https://doi.org/10.1126/science.aaa1348
A neoantigen fitness model predicts tumour response to checkpoint blockade immunotherapy
M. Łuksza, N. Riaz, V. Makarov, et al.. (2017). Nature. Cited 573 times.
https://doi.org/10.1038/nature24473
